System Transmission

Top Signal

100#1 JOB

Activity

2175Ripe

+931 today

System

Livenow

Terminal Asset View

stockNASDAQ

BNTC

$11.75-3.05%

Benitec Biopharma Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

19Overripe

Live Analysis Active

Company Mission

Benitec Biopharma creates gene-based treatments for rare genetic diseases. Their technology works by targeting specific genes to treat conditions that have few other treatment options. The company makes money through research grants and by partnering with larger pharmaceutical companies to develop and potentially commercialize their therapies.

BNT

Industry Context

The biotechnology industry focuses on developing medical treatments using biological systems. Companies in this sector often work on treatments for rare diseases, which can be risky but potentially rewarding if successful. Many biotech firms rely on partnerships with larger pharmaceutical companies and research grants to fund their development work.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

60Matrix

Market Momentum

52.5— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.6x— Normal Volume

Today's Change

-3.05%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing BNTC across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 03:38 AM UTC

As-of 03-15-2026 03:23 UTC

Develops gene therapies that treat rare diseases and makes money by licensing its technology to pharmaceutical companies.

No price data available, suggesting limited trading activity which often indicates low investor interest in the current market.

Biotech sector faces funding challenges as interest rates remain high, requiring monitoring of partnership announcements for potential catalysts, suggesting potential catalysts.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...